本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Alpha Tau Medical

3.93
+0.15003.97%
盤後3.930.00000.00%16:10 EDT
成交量:2.11萬
成交額:8.15萬
市值:3.34億
市盈率:-8.12
高:4.25
開:3.80
低:3.79
收:3.78
52周最高:4.69
52周最低:2.12
股本:8,504.32萬
流通股本:5,713.21萬
量比:0.28
換手率:0.04%
股息:- -
股息率:- -
每股收益(TTM):-0.4839
每股收益(LYR):-0.4540
淨資產收益率:-43.83%
總資產收益率:-22.66%
市淨率:3.86
市盈率(LYR):-8.66

資料載入中...

2025/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/30

SEC問詢函

Form CORRESP - Correspondence
2025/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/20

SEC問詢函

Form CORRESP - Correspondence
2023/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/04/11

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/23

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/18

SEC問詢函

CORRESP [Cover] - Correspondence